Skip to main content
Premium Trial:

Request an Annual Quote

Sequenom, CombiMatrix Collaborate to Market NIPD Testing with CMA

NEW YORK (GenomeWeb News) – Sequenom and CombiMatrix today announced an agreement to market chromosomal microarray analysis testing services "to broaden and confirm the results of non-invasive prenatal testing" to doctors and patients.

Under the terms of the deal, the Sequenom Center for Molecular Medicine and CombiMatrix will promote the use of NIPD testing and CMA, as well as provide technical training to physicians. They also will provide counseling, educational, and support services to physicians and their patients, they said.

Additionally, the two companies plan to provide a comprehensive test result report for ordering physicians, when clinically appropriate.

Sequenom offers the MaterniT21 Plus test for trisomy 21, 18, and 13 and X and Y chromosomal material in cell-free DNA. In a statement, Sequenom President and COO Bill Welch said "for an important group of patients a chromosomal microarray test can be a significant adjunct for a comprehensive prenatal analysis. CombiMatrix specializes in CMA, and their technology helps further expand our product offering in the growing prenatal genetic testing marketplace."

Financial and other terms of the deal were not disclosed.

In Thursday morning trade on the Nasdaq, shares of CombiMatrix climbed 9 percent to $3.53, while Sequenom's stock was up a fraction of a percent at $3.02.

The Scan

Cell Atlas of Human Lung Development Gives View of Developing Airway

Researchers have generated a cell atlas of human lung development, which they report in Cell.

Study Finds Costs of Genome Sequencing May Limit Utility in Routine Care

Researchers report in the European Journal of Human Genetics that genome sequencing for rare disease diagnoses currently has similar benefits as less expensive exome analysis.

Study Suggests Nursing Mother's Diet Can Impact Offspring's Gut Microbiome

A new Cell Host and Microbe paper finds that mice whose mothers were fed a low-fiber diet during nursing experience lasting microbiota dysbiosis and increased obesity.

Study Links Genetic Risk for ADHD With Alzheimer's Disease

A higher polygenic risk score for attention-deficit/hyperactivity disorder is also linked to cognitive decline and Alzheimer's disease, a new study in Molecular Psychiatry finds.